Summary
Updated Aug 31, 2026
Karen L. Smith is Director of Context Therapeutics Inc. (CNTX). 7 SEC Form 4 filings on record going back to 2024, most recently on 26 June 2026. Most recent open-market trade: sold $44K of AUPH on 12 November 2024. Lifetime open-market sales: $44K.
Recent Transactions
4Every recent SEC Form 4 transaction Karen L. Smith has reported, most recent first.
Most Active Insiders Right Now
Karen L. Smith has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Brannin McBee - $112.75M of CRWV open-market activity in the last 90 days
- Richard Adam Norwitt - $110.99M of APH open-market activity in the last 90 days
- Brian Chesky - $109.51M of ABNB open-market activity in the last 90 days
- Benoit Dageville - $108.67M of SNOW open-market activity in the last 90 days
- Gary E. Dickerson - $104.79M of AMAT open-market activity in the last 90 days
- Abu Dhabi Investment Authority - $104.73M of JMKE open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Karen L. Smith?
Karen L. Smith is a corporate insider, tracked as Director of Context Therapeutics Inc. (CNTX). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Karen L. Smith submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Karen L. Smith been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($44K) across all tracked filings.
Where can I see all of Karen L. Smith's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Karen L. Smith and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
